Shuang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuang Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Dan Yu
Department of Otorhinolaryngology, Head and Neck Surgery The Second Hospital of Jilin University Changchun China
3 shared publicationsXue Zhao
Department of Otorhinolaryngology, Head and Neck Surgery The Second Hospital of Jilin University Changchun China
2 shared publicationsDhan V. Kalvakolanu
University of Maryland School of Medicine
1 shared publicationDi Wang
Jilin University Second Hospital
1 shared publicationDing Wang
Jilin University
1 shared publicationHaixian Guo
Department of Otorhinolaryngology, Head and Neck Surgery The Second Hospital of Jilin University Changchun China
1 shared publication
Latest Publications
- 10 August 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , 5474-5481
Multi‐Classification of Vocal Cord Masses via Local‐Higher Order Graph Neural Network on Voice Data
Objective: To develop an intelligent diagnostic model based on a Local‐Higher Order Graph Neural Network (LHGNN) to achieve noninvasive auxiliary multi‐class pathological classification of vocal fold tumors by analyzing Mel‐spectrograms of voice data. Methods: Patients with pathologically confirmed vocal fold polyps ( n = 1272), premalignant lesions ( n = 180), and malignant tumors ( n = 197) were retrospectively identified. Patients were divided into training and validation sets in a ratio of 8:2. The patient's vowel and continuous sentence audio were collected, and the audio was segmented and converted into Mel‐spectrograms. The data was enhanced by random occlusion, adding noise and time shifting. We used a convolutional backbone network‐based LHGNN architecture, whose core consists of multiple cascaded LHG modules. The model was evaluated using metrics including accuracy, recall, F 1‐score, and the area under the curve (AUC) value. Results: The final dataset comprised 4745 audio samples after balanced sampling (1603 vocal fold polyps, 1598 premalignant lesions, 1544 vocal fold carcinomas). The validation set achieved optimal performance after 461 training epochs: overall accuracy of 92.94%, F 1‐score of 0.9289, recall of 0.9281, and AUC of 0.9877. The multi‐class confusion matrix demonstrated identification accuracies of 91.35% for vocal fold polyps, 90.99% for premalignant lesions, and 94.05% for malignant tumors. Conclusion: This study successfully validated the high efficacy of the LHGNN model in the multi‐class classification of vocal fold tumors. Its excellent performance highlights the significant potential of deep learning in vocal pathological analysis. The model provides a new tool for the noninvasive preliminary screening of vocal fold tumors. Level of Evidence: 3.
- 10 August 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , 5474-5481
Multi‐Classification of Vocal Cord Masses via Local‐Higher Order Graph Neural Network on Voice Data
Objective: To develop an intelligent diagnostic model based on a Local‐Higher Order Graph Neural Network (LHGNN) to achieve noninvasive auxiliary multi‐class pathological classification of vocal fold tumors by analyzing Mel‐spectrograms of voice data. Methods: Patients with pathologically confirmed vocal fold polyps ( n = 1272), premalignant lesions ( n = 180), and malignant tumors ( n = 197) were retrospectively identified. Patients were divided into training and validation sets in a ratio of 8:2. The patient's vowel and continuous sentence audio were collected, and the audio was segmented and converted into Mel‐spectrograms. The data was enhanced by random occlusion, adding noise and time shifting. We used a convolutional backbone network‐based LHGNN architecture, whose core consists of multiple cascaded LHG modules. The model was evaluated using metrics including accuracy, recall, F 1‐score, and the area under the curve (AUC) value. Results: The final dataset comprised 4745 audio samples after balanced sampling (1603 vocal fold polyps, 1598 premalignant lesions, 1544 vocal fold carcinomas). The validation set achieved optimal performance after 461 training epochs: overall accuracy of 92.94%, F 1‐score of 0.9289, recall of 0.9281, and AUC of 0.9877. The multi‐class confusion matrix demonstrated identification accuracies of 91.35% for vocal fold polyps, 90.99% for premalignant lesions, and 94.05% for malignant tumors. Conclusion: This study successfully validated the high efficacy of the LHGNN model in the multi‐class classification of vocal fold tumors. Its excellent performance highlights the significant potential of deep learning in vocal pathological analysis. The model provides a new tool for the noninvasive preliminary screening of vocal fold tumors. Level of Evidence: 3.
- Open Access
- 20 July 2022
- Published by Springer Nature in Research Square
A Photodynamically Sensitized Dendritic Cell Vaccine that Promotes the Anti-Tumor effects of Anti-PD-L1 Monoclonal Antibody in Head and Neck Squamous Cell Carcinoma
Background . Immune checkpoint inhibitors are promising tools in combating several cancers, including head and neck squamous cell carcinoma (HNSCC). However, a substantial portion of HNSCC patients do not respond to PD-L1 antibody. Here we describe a photodynamic therapeutic (PDT) approach to enhance anti-tumor effects of the anti-PD-L1 antibody. Methods . Phototoxicity of PDT was confirmed using fluorescence microscopy, Cell Counting Kit-8 (CCK-8), Enzyme Linked Immunosorbent Assay (ELISA) and flow cytometry analyses. Phenotypic and functional maturation of immature DCs (imDCs) induced by PDT were measured using flow cytometry and ELISA. A mouse model was established using the HNSCC line, SCC7, and was used to evaluate therapeutic effects of PDT-DC vaccine in facilitating anti-tumor immunity of PD-L1 antibody. Results . Immunogenic cell death (ICD) of SCC7 cells was induced by PDT with 0.5 μM of m-THPC and the 5 J/cm2 of light dose. ICD of SCC7 cells stimulated imDCs maturation. In vivo assays suggested that PDT-DC vaccine and anti-PD-L1 mAb synergistically induced anti-tumor immunity and suppressed tumor progression. Conclusions . PDT-DC vaccine enhances therapeutic effects of PD-L1 antibody, which might provide a novel approach for HNSCC immunotherapy.
- 20 July 2022
- Published by Springer Nature in Research Square
Open AccessA Photodynamically Sensitized Dendritic Cell Vaccine that Promotes the Anti-Tumor effects of Anti-PD-L1 Monoclonal Antibody in Head and Neck Squamous Cell Carcinoma
Background . Immune checkpoint inhibitors are promising tools in combating several cancers, including head and neck squamous cell carcinoma (HNSCC). However, a substantial portion of HNSCC patients do not respond to PD-L1 antibody. Here we describe a photodynamic therapeutic (PDT) approach to enhance anti-tumor effects of the anti-PD-L1 antibody. Methods . Phototoxicity of PDT was confirmed using fluorescence microscopy, Cell Counting Kit-8 (CCK-8), Enzyme Linked Immunosorbent Assay (ELISA) and flow cytometry analyses. Phenotypic and functional maturation of immature DCs (imDCs) induced by PDT were measured using flow cytometry and ELISA. A mouse model was established using the HNSCC line, SCC7, and was used to evaluate therapeutic effects of PDT-DC vaccine in facilitating anti-tumor immunity of PD-L1 antibody. Results . Immunogenic cell death (ICD) of SCC7 cells was induced by PDT with 0.5 μM of m-THPC and the 5 J/cm2 of light dose. ICD of SCC7 cells stimulated imDCs maturation. In vivo assays suggested that PDT-DC vaccine and anti-PD-L1 mAb synergistically induced anti-tumor immunity and suppressed tumor progression. Conclusions . PDT-DC vaccine enhances therapeutic effects of PD-L1 antibody, which might provide a novel approach for HNSCC immunotherapy.
- 1 June 2021
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 40 (6) , 720-732
Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments
Many kinds of cancer cells are intrinsically sensitive to ferroptosis, and research interest regarding ferroptosis has been sparked by its significant role in many detrimental diseases. Ferroptosis is a novel type of iron-dependent cell death mediated by accumulation of reactive oxygen species and lipid peroxidation. Furthermore, a large number of small agents can induce ferroptosis in numerous kinds of cancer cells, including prostate cancer, pancreatic cancer, breast cancer, lymphomas, and renal cancer. These insights may help discover novel approaches for cancer therapeutic strategies; however, there is considerable uncertainty regarding ferroptosis in head and neck cancer (HNC). So far, no review of the current studies on this topic has been published. Therefore, we here elaborate the mechanisms of ferroptosis and summarize the latest findings regarding its role in HNC according to current literature. The respective findings shed light on the role of ferroptosis in HNC treatment with a number of important implications for future practice in HNC management, as outlined in this review.
- 1 June 2021
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 40 (6) , 720-732
Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments
Many kinds of cancer cells are intrinsically sensitive to ferroptosis, and research interest regarding ferroptosis has been sparked by its significant role in many detrimental diseases. Ferroptosis is a novel type of iron-dependent cell death mediated by accumulation of reactive oxygen species and lipid peroxidation. Furthermore, a large number of small agents can induce ferroptosis in numerous kinds of cancer cells, including prostate cancer, pancreatic cancer, breast cancer, lymphomas, and renal cancer. These insights may help discover novel approaches for cancer therapeutic strategies; however, there is considerable uncertainty regarding ferroptosis in head and neck cancer (HNC). So far, no review of the current studies on this topic has been published. Therefore, we here elaborate the mechanisms of ferroptosis and summarize the latest findings regarding its role in HNC according to current literature. The respective findings shed light on the role of ferroptosis in HNC treatment with a number of important implications for future practice in HNC management, as outlined in this review.